China's First Domestic HPV Vaccine Shows 100 Pct Efficacy in Clinical Trial
Release time：2024-05-21 12:23:46 Source：Global Groove news portal
-
Contact Us
- Home
- News
- People
- In-depth
- ACWF
- 2023 Women Science and Technology Innovation Pioneer...
- People Enjoy Blooming Tulips in Jinan, East...
- Flowers Bloom Across China in Spring
China's First Domestic HPV Vaccine Shows 100 Pct Efficacy in Clinical Trial
September 1, 2022 |
| A nurse shows human papillomavirus (HPV) vaccines developed by Chinese researchers at the provincial Maternity and Child Healthcare Hospital in Wuhan, central China's Hubei Province, May 18, 2020. [Xinhua/Xiong Qi] |
BEIJING, Aug. 30 (Xinhua) — A recent study has found that China's first self-developed HPV vaccine Cecolin can offer women adults full immunity against two types of human papillomavirus (HPV).
A group of Chinese researchers analyzed data from 66-month follow-up visits as a part of the bivalent vaccine's Phase 3 clinical trial and found that its efficacy against high-grade genital lesions, typical symptoms of cervical cancer, reached 100 percent.
Furthermore, the E coli-produced HPV 16/18 recombinant vaccine realized a 97 percent efficacy against persistent HPV infections, according to the study published in the journal Lancet Infectious Diseases.
The clinical trial included 7,372 healthy women aged 18 to 45, with 3,689 in the vaccinated group and 3,683 in the control group. The cumulative incidence in the vaccinated group was noticeably lower than that in the control group, according to the study.
Cecolin is jointly developed by Xiamen University and Xiamen Innovax, making China the third country in the world to attain an independent cervical cancer vaccine supply after the United States and the United Kingdom. It earned the World Health Organization Prequalification in October 2021.
(Source: Xinhua)
32.3KPlease understand that womenofchina.cn,a non-profit, information-communication website, cannot reach every writer before using articles and images. For copyright issues, please contact us by emailing: [email protected]. The articles published and opinions expressed on this website represent the opinions of writers and are not necessarily shared by womenofchina.cn.
Comments
Magazines
Projects
Photos
Special Coverage
- Previous：Strictly star Giovanni Pernice's former partner Rose Ayling
- Next：Insider Q&A: CIA's chief technologist's cautious embrace of generative AI
Related articles
- Kosovo prepares a new draft law on renting prison cells to Denmark after the first proposal failed
- Chinese premier chairs meeting to solicit opinions on economic work
- China greets green tomb
- Shen Attends SCO Forum on People
- Supreme Court declines to hear challenge to Maryland ban on rifles known as assault weapons
- Shen Delivers Remark During Opening Ceremony of Third SCO Women's Forum
- Aerospace·Dream — Spring Bud Project Launched
- Shen Addresses via Video Link at Fourth SCO Women's Forum
- Red Lobster seeks bankruptcy protection after closing some restaurants
- National Campaign on Caring for Children in Winter Vacation Launched
- Shohei Ohtani's first walk
- ACWF Holds Meeting for Presidents of Provincial
- ACWF Celebrates China
- Shen Delivers Remark During Opening Ceremony of Third SCO Women's Forum
- Fresh heartache for cancer
- ACWF Enhances Capacity Building for Women's Social Organizations in Western China
- ACWF Calls on Women to Follow Party's Leadership, Embark on New Journey
- Leaders of Women's Institutions, Organizations of Lancang
- Amir Khan's £11.5m luxury wedding venue finally hosts its first marriage: Bride arrives on horse
- Huang Addresses Second Women Power Forum, Inaugural Ceremony of HKFW's Board (2021
Random recommendation
- Copyright © 2024 Powered by China's First Domestic HPV Vaccine Shows 100 Pct Efficacy in Clinical Trial ,Global Groove news portal sitemap